In-Depth Cerebrospinal
Fluid Quantitative Proteome
and Deglycoproteome Analysis: Presenting a Comprehensive Picture of
Pathways and Processes Affected by Multiple Sclerosis
posted on 2016-10-11, 00:00authored byAnn Cathrine Kroksveen, Astrid Guldbrandsen, Marc Vaudel, Ragnhild Reehorst Lereim, Harald Barsnes, Kjell-Morten Myhr, Øivind Torkildsen, Frode S. Berven
In the current study,
we conducted a quantitative in-depth proteome
and deglycoproteome analysis of cerebrospinal fluid (CSF) from relapsing-remitting
multiple sclerosis (RRMS) and neurological controls using mass spectrometry
and pathway analysis. More than 2000 proteins and 1700 deglycopeptides
were quantified, with 484 proteins and 180 deglycopeptides significantly
changed between pools of RRMS and pools of controls. Approximately
300 of the significantly changed proteins were assigned to various
biological processes including inflammation, extracellular matrix
organization, cell adhesion, immune response, and neuron development.
Ninety-six significantly changed deglycopeptides mapped to proteins
that were not found changed in the global protein study. In addition,
four mapped to the proteins oligo-myelin glycoprotein and noelin,
which were found oppositely changed in the global study. Both are
ligands to the nogo receptor, and the glycosylation of these proteins
appears to be affected by RRMS. Our study gives the most extensive
overview of the RRMS affected processes observed from the CSF proteome
to date, and the list of differential proteins will have great value
for selection of biomarker candidates for further verification.